Royalty Pharma Past Performance
How has Royalty Pharma performed over the past 5 years?
[object Object] Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RPRX has high quality earnings.
Growing Profit Margin: RPRX's current net profit margins (22.6%) are lower than last year (34.2%).
Past Earnings Growth Analysis
Earnings Trend: RPRX's earnings have declined by 26.5% per year over the past 5 years.
Accelerating Growth: RPRX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: RPRX had negative earnings growth (-35.3%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (8.4%).
Return on Equity
High ROE: RPRX's Return on Equity (8.6%) is considered low.